KR900700499A - 9α-히드록시-17-메틸렌 스테로이드 그의 제조방법 및 코르티코스테로이드 제조에의 이용 - Google Patents

9α-히드록시-17-메틸렌 스테로이드 그의 제조방법 및 코르티코스테로이드 제조에의 이용

Info

Publication number
KR900700499A
KR900700499A KR1019890702133A KR890702133A KR900700499A KR 900700499 A KR900700499 A KR 900700499A KR 1019890702133 A KR1019890702133 A KR 1019890702133A KR 890702133 A KR890702133 A KR 890702133A KR 900700499 A KR900700499 A KR 900700499A
Authority
KR
South Korea
Prior art keywords
hydroxy
preparation
methylene steroid
corticosteroid production
steroid method
Prior art date
Application number
KR1019890702133A
Other languages
English (en)
Other versions
KR0138777B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR900700499A publication Critical patent/KR900700499A/ko
Application granted granted Critical
Publication of KR0138777B1 publication Critical patent/KR0138777B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/009—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
KR1019890702133A 1988-04-08 1989-04-07 9α-히드록시-17-메틸렌 스테로이드, 그의 제조방법 및 코르티코스테로이드 제조에의 이용 KR0138777B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP88200675.2 1988-04-08
EP88200675 1988-04-08
PCT/NL1989/000020 WO1989009781A1 (en) 1988-04-08 1989-04-07 9-alpha-hydroxy-17-methylene steroids, their preparation and utilization

Publications (2)

Publication Number Publication Date
KR900700499A true KR900700499A (ko) 1990-08-13
KR0138777B1 KR0138777B1 (ko) 1998-04-30

Family

ID=8199778

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890702133A KR0138777B1 (ko) 1988-04-08 1989-04-07 9α-히드록시-17-메틸렌 스테로이드, 그의 제조방법 및 코르티코스테로이드 제조에의 이용

Country Status (18)

Country Link
US (1) US5194602A (ko)
EP (1) EP0336521B1 (ko)
JP (1) JP2812397B2 (ko)
KR (1) KR0138777B1 (ko)
CN (2) CN1187365C (ko)
AU (1) AU618350B2 (ko)
CA (1) CA1332409C (ko)
DE (1) DE68901104D1 (ko)
DK (1) DK175401B1 (ko)
ES (1) ES2033516T3 (ko)
FI (1) FI108436B (ko)
GR (1) GR3004539T3 (ko)
HU (1) HU208437B (ko)
IE (1) IE62277B1 (ko)
IL (1) IL89880A (ko)
NO (1) NO300894B1 (ko)
PT (1) PT90227B (ko)
WO (1) WO1989009781A1 (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY105302A (en) * 1989-11-27 1994-09-30 Schering Corp Process for dehydrating corticosteroid intermediates.
FR2677029B1 (fr) * 1991-05-23 1994-01-21 Roussel Uclaf Nouveaux derives sterouides de l'andostra-4,9(11),16-trien-3-one.
FR2677028B1 (fr) * 1991-05-23 1994-01-21 Roussel Uclaf Nouveaux derives sterouides du pregna-4,9(11),17(20)-trien-3-one.
FR2676740B1 (fr) * 1991-05-23 1993-11-05 Roussel Uclaf Nouveaux derives sterouides du pregna-4,9(11),17(20)-trie-3-one, leur preparation, leur application a la preparation de composes sterouides de type pregna-4,9(11),16-triene-3,20-dione et nouveaux intermediaires.
FR2681069B1 (fr) * 1991-09-06 1995-04-28 Roussel Uclaf Nouveau procede de preparation de l'hydrocortisone et nouveaux intermediaires.
FR2683530B1 (fr) * 1991-11-08 1994-01-21 Roussel Uclaf Nouveau procede de preparation de derives 20-oxo 17 alpha, 21-dihydroxyles du pregnane et nouveaux intermediaires.
WO1993015103A2 (en) * 1992-01-28 1993-08-05 Schering Corporation Novel steroid intermediates and processes for their preparation
CN1061984C (zh) * 1996-04-18 2001-02-14 上海华联制药有限公司 甾体激素化合物中引入9-11双键的一种方法
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6855836B2 (en) * 2000-10-26 2005-02-15 Jenapharm Gmbh & Co. Kg 17-Methylene steroids, process for their production and pharmaceutical compositions that contain these compounds
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
US20080318870A1 (en) 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
MX360094B (es) * 2007-06-19 2018-10-19 Kythera Biopharmaceuticals Inc Star Composición, método y preparación del ácido biliar sintético.
JOP20180077A1 (ar) 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
BR112013003216A2 (pt) 2010-08-12 2016-05-17 Kythera Biopharmaceuticals Inc composições sintéticas de ácido biliar e métodos
WO2013044119A1 (en) * 2011-09-22 2013-03-28 Kythera Biopharmaceuticals, Inc. Compositions and methods related to deoxycholic acid and its polymorphs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL103170C (ko) * 1958-11-14
DE1568506A1 (de) * 1966-03-23 1970-07-16 Hoechst Ag Verfahren zur Herstellung von delta?-Pregnen-3,21-diol-20-on-21-acylaten
US3445907A (en) * 1967-02-16 1969-05-27 Ind Tectonics Inc Roller retaining method for roller bearing separators
US4255344A (en) * 1978-11-08 1981-03-10 Mitsubishi Chemical Industries, Limited 9-α-Hydroxy steroids
FR2462445A1 (fr) * 1979-07-31 1981-02-13 Roussel Uclaf Nouveaux derives 17-/(hydroxymethyl) (formamido) methylene/steroides, leur procede de preparation et leur application a l'introduction de la chaine laterale hydroxyacetyle
FR2486947A1 (fr) * 1980-07-15 1982-01-22 Roussel Uclaf Nouveaux derives steroides 20-isonitriles 17(20) insatures, leur procede de preparation et leur application a la preparation des steroides 17a-hydroxy 20-ceto
DE3136917A1 (de) * 1980-09-27 1982-05-19 Barmag Barmer Maschinenfabrik Ag, 5630 Remscheid "kraftstoffoerderpumpe"
FR2493324B1 (ko) * 1980-11-05 1983-01-21 Roussel Uclaf
FR2521567A1 (fr) * 1982-02-18 1983-08-19 Roussel Uclaf Nouveaux derives steroides 17(20)nitro, leur procede de preparation et leur application a la preparation de corticosteroides
EP0123734A1 (en) * 1983-04-29 1984-11-07 Gist-Brocades N.V. 17-(Isocyano-sulfonylmethylene)-steroids, 17-(formamido-sulfonylmethylene)-steroids and their preparation

Also Published As

Publication number Publication date
IL89880A (en) 1994-06-24
KR0138777B1 (ko) 1998-04-30
JP2812397B2 (ja) 1998-10-22
US5194602A (en) 1993-03-16
DK240890A (da) 1990-10-05
FI904877A0 (fi) 1990-10-03
IL89880A0 (en) 1989-12-15
GR3004539T3 (ko) 1993-04-28
DK240890D0 (da) 1990-10-05
DK175401B1 (da) 2004-09-27
HUT55411A (en) 1991-05-28
IE891134L (en) 1989-10-08
AU618350B2 (en) 1991-12-19
NO904333L (no) 1990-12-03
DE68901104D1 (de) 1992-05-07
NO904333D0 (no) 1990-10-05
PT90227B (pt) 1994-06-30
CN1141301A (zh) 1997-01-29
PT90227A (pt) 1989-11-10
JPH03503645A (ja) 1991-08-15
IE62277B1 (en) 1995-01-25
FI108436B (fi) 2002-01-31
NO300894B1 (no) 1997-08-11
CN1036774A (zh) 1989-11-01
EP0336521A1 (en) 1989-10-11
WO1989009781A1 (en) 1989-10-19
EP0336521B1 (en) 1992-04-01
CN1187365C (zh) 2005-02-02
HU208437B (en) 1993-10-28
AU3431389A (en) 1989-11-03
CA1332409C (en) 1994-10-11
CN1032211C (zh) 1996-07-03
HU892602D0 (en) 1991-03-28
ES2033516T3 (es) 1993-03-16

Similar Documents

Publication Publication Date Title
KR900700499A (ko) 9α-히드록시-17-메틸렌 스테로이드 그의 제조방법 및 코르티코스테로이드 제조에의 이용
KR890700129A (ko) 9-알파-히드록시 스테로이드 및 그의 제조방법과 상기 스테로이드 함유 대응9-데히드로 유도체 및 제약제제의 제조방법
DE3471584D1 (en) Dermatological composition and preparation method thereof
KR860002503A (ko) 트랜스-6-[2-알킬]-피란-2-온 및 그 제조방법
HUT52114A (en) Process for producing new estragen derivatives with steroid hormone-inhibiting effect and pharmaceutical compositions comprising such derivatives
PH19849A (en) Steroids and their pharmaceutical composition
ZA881488B (en) New pharmaceutical compositions in the form of beadlets and method
KR900701424A (ko) 별형상 패스너의 제조방법 및 장치
DE3779881D1 (de) Steroid-derivate und verfahren zu ihrer herstellung.
KR890016060A (ko) N2--l-리신 유도체 및 이를 사용한 리시노프릴의 제조방법
DK300990A (da) Tricycliske 3-oxo-propannitrilderivater og fremgangsmaade til fremstilling deraf
FI101551B1 (fi) Menetelmä progesteronin moninkertaiseksi hapettamiseksi ja menetelmässä käytettävät geeniteknisesti muunnetut solut
YU162589A (en) Platinum (iv)-diaminic complex and process for obtaining thereof
EP0321572A4 (en) PREGNANE DERIVATIVES AND PREPARATION METHOD.
KR900004691A (ko) 페닐피리딘 및 이의 제조방법
EP0302331A3 (en) Esters of arylbisperfluoralkylcarbinols, method for the preparation of the same and of the arylbisperfluoralkylcarbinols in question
GB2234255B (en) Methylpolysilanes and method for their preparation
JPS52139086A (en) Quinazoline derivative and method for its preparation
AU3864589A (en) Length measuring method and means
DE3360856D1 (en) Pregnane derivatives and method of producing the same
IT1204911B (it) 3-deoxo-10beta-alchinil steroidi e procedimento per la loro preparazione
PL275765A1 (en) Preparation method for cumophenyl and/or its methyl derivatives
GB8902058D0 (en) Improvements in methods and apparatus for supporting structures
DK499085D0 (da) Ergolinderivater og deres anvendelse i farmaceutiske midler
ES538996A0 (es) Procedimiento para la obtencion por esterificacion de derivados salicilicos y acetilsalicilicos en c-21 de un esteroide pregnanico 9-clorado

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120206

Year of fee payment: 15

EXPY Expiration of term